MSVEX Mutual Fund (Vitality Portfolio Class A) is managed by Morgan Stanley Investment Management. MSVEX expense ratio is 1.30%, holding 33 positions across sectors including Health Care, Unknown, Information Technology. Inception date: 2021-12-31.

MSVEX performance shows a YTD return of 1.07%. The 1-year return is 29.13%. MSVEX dividend yield stands at 1.21%, paid annually.

MSVEX top holdings include Argenx Se Spon Adr Each Rep 1 Ord Shs (8.0%), Eli Lilly & Co (7.8%), Ascendis Pharma As Adr (5.5%), Nektar Therapeutics Class A (4.8%), Thermo Fisher (4.3%). View all MSVEX holdings, sector breakdown, or dividend history.

MSVEX can be compared against other funds using the overlap calculator or side-by-side comparison tool. MSVEX alternatives are available via the screener, along with tax-loss harvesting opportunities.